Kimberly Gentile serves as Executive at Biohaven Pharmaceutical Holding Co Ltd., where they oversee executive responsibilities. Since joining the company, Kimberly Gentile has executed 65 insider transactions totaling $6.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2018 involved exercising options for 5,000 shares valued at $3.0K.
Kimberly Gentile currently holds 7,500 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kimberly Gentile has been a net seller of BHVN stock. They have purchased $0 and sold $6.1M worth of shares.
Kimberly Gentile's most recent insider trade was on Mar 1, 2018, when they sold 5,000 shares at $0.61 per share.
Get notified when new Form 4 filings are submitted
| $32.42 |
| Discretionary |
| Feb 1, 2018 | BHVN | $45.2K | Sale | 1,348 | $33.53 | Discretionary |
| Feb 1, 2018 | BHVN | $3.0K | Option Exercise | 5,000 | $0.61 | Discretionary |
| Feb 1, 2018 | BHVN | $10.2K | Sale | 300 | $33.99 | Discretionary |
| Feb 1, 2018 | BHVN | $108.5K | Sale | 3,352 | $32.37 | Discretionary |
| Jan 2, 2018 | BHVN | $138.0K | Sale | 5,000 | $27.60 | Discretionary |
| Jan 2, 2018 | BHVN | $3.0K | Option Exercise | 5,000 | $0.61 | Discretionary |
| Dec 1, 2017 | BHVN | $4.6K | Sale | 200 | $23.04 | Discretionary |
| Dec 1, 2017 | BHVN | $62.7K | Sale | 2,798 | $22.42 | Discretionary |
| Dec 1, 2017 | BHVN | $42.6K | Sale | 2,002 | $21.29 | Discretionary |
| Dec 1, 2017 | BHVN | $3.0K | Option Exercise | 5,000 | $0.61 | Discretionary |
| Nov 1, 2017 | BHVN | $104.5K | Sale | 3,586 | $29.13 | Discretionary |
| Nov 1, 2017 | BHVN | $41.9K | Sale | 1,414 | $29.65 | Discretionary |
| Nov 1, 2017 | BHVN | $3.0K | Option Exercise | 5,000 | $0.61 | Discretionary |